Ignite Creation Date:
2024-05-05 @ 4:49 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00320411
Status:
COMPLETED
Last Update Posted:
2019-01-31
First Post:
2006-05-01
Brief Title:
GW572016 In Patients With ErbB2 Over - Expressing Advanced Or Metastatic Breast Cancer
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-11-28
Start Date Type:
None
Primary Completion Date:
2009-04-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-04-01
Completion Date Type:
ACTUAL
First Submit Date:
2006-05-01
First Submit QC Date:
May 1 2006
Study First Post Date:
2006-05-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2009-12-14
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-08-30
Last Update Post Date:
2019-01-31
Last Update Post Date Type:
ACTUAL